Cargando…

PCDH18 is frequently inactivated by promoter methylation in colorectal cancer

Protocadherin18 (PCDH18) was found to be preferentially methylated and inactivated in colorectal cancer (CRC) using bioinformatics tools. However, its biologic role in tumorgenesis remains unclear. Herein, we aimed to elucidate its epigenetic regulation and biological functions in CRC. The methylati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Dan, Tang, Weiwei, Su, Guoqiang, Cai, Mingquan, An, Han-Xiang, Zhang, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460281/ https://www.ncbi.nlm.nih.gov/pubmed/28588296 http://dx.doi.org/10.1038/s41598-017-03133-w

Ejemplares similares

PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance
por: Zhang, Cheng, et al.
Publicado: (2016)

JAM3 functions as a novel tumor suppressor and is inactivated by DNA methylation in colorectal cancer
por: Zhou, Dan, et al.
Publicado: (2019)

Promoter methylation of PCDH10 by HOTAIR regulates the progression of gastrointestinal stromal tumors
por: Lee, Na Keum, et al.
Publicado: (2016)

Epigenetic alteration: new insights moving from tissue to plasma – the example of PCDH10 promoter methylation in colorectal cancer
por: Danese, E, et al.
Publicado: (2013)

Aberrant promoter methylation of PCDH10 as a potential diagnostic and prognostic biomarker for patients with breast cancer
por: Liu, Wentao, et al.
Publicado: (2018)

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
por: Huang, Wenting, et al.
Publicado: (2017)

Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma
por: Lin, Ying-Li, et al.
Publicado: (2017)

PCDH9 acts as a tumor suppressor inducing tumor cell arrest at G(0)/G(1) phase and is frequently methylated in hepatocellular carcinoma
por: Lv, Jun, et al.
Publicado: (2017)

Comparative characterization of PCDH19 missense and truncating variants in PCDH19-related epilepsy
por: Shibata, Mami, et al.
Publicado: (2020)

Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer
por: Lin, Ying-Li, et al.
Publicado: (2014)

PCDH17 gene promoter methylation status in a cohort of Egyptian women with epithelial ovarian cancer
por: Elsharkawi, Sherif Mohamed, et al.
Publicado: (2023)

Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma
por: Hayashi, Takehiro, et al.
Publicado: (2017)

Mosaicism and incomplete penetrance of PCDH19 mutations
por: Liu, Aijie, et al.
Publicado: (2019)

Brain calcifications and PCDH12 variants
por: Nicolas, Gaël, et al.
Publicado: (2017)

Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients
por: Deng, Qiu-Kui, et al.
Publicado: (2016)

Pcdh18a regulates endocytosis of E-cadherin during axial mesoderm development in zebrafish
por: Bosze, Bernadett, et al.
Publicado: (2020)

Mieap-regulated mitochondrial quality control is frequently inactivated in human colorectal cancer
por: Kamino, H, et al.
Publicado: (2016)

Cadherin-11 is inactivated due to promoter methylation and functions in colorectal cancer as a tumour suppressor
por: Yuan, Shiyun, et al.
Publicado: (2019)

High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
por: Curia, Maria Cristina, et al.
Publicado: (2019)

E3 ubiquitin ligase RNF180 prevents excessive PCDH10 methylation to suppress the proliferation and metastasis of gastric cancer cells by promoting ubiquitination of DNMT1
por: Zhang, Nannan, et al.
Publicado: (2023)

The role of Pcdh10 in neurological disease and cancer
por: Zhen, Yilan, et al.
Publicado: (2023)

Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer
por: Cheng, Y Y, et al.
Publicado: (2007)

PCDH17 increases the sensitivity of colorectal cancer to 5-fluorouracil treatment by inducing apoptosis and autophagic cell death
por: Liu, Shuiping, et al.
Publicado: (2019)

Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer
por: Lin, Ying-Li, et al.
Publicado: (2017)

Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma
por: Butler, L M, et al.
Publicado: (2000)

Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies
por: Zhou, Dan, et al.
Publicado: (2016)

PCDH7 Inhibits the Formation of Homotypic Cell-in-Cell Structure
por: Wang, Chenxi, et al.
Publicado: (2020)

The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers
por: Marie Vedeld, Hege, et al.
Publicado: (2015)

Association between the methylation status of PCDH17 and the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer
por: Kong, De-Di, et al.
Publicado: (2020)

Adjuvant Treatment for Protocadherin 19 (PCDH19) Syndrome
por: Moncayo, Juan A, et al.
Publicado: (2022)

PCDH9 suppresses melanoma proliferation and cell migration
por: Zhang, Jiaojiao, et al.
Publicado: (2022)

PCDH19 in Males: Are Hemizygous Variants Linked to Autism?
por: Chouery, Eliane, et al.
Publicado: (2023)

Novel and de novo mutation of PCDH19 in Girls Clustering Epilepsy
por: Yang, Li, et al.
Publicado: (2019)

Promoter Methylation of SFRP3 Is Frequent in Hepatocellular Carcinoma
por: Lin, Ya-Wen, et al.
Publicado: (2014)

FLRT2 functions as Tumor Suppressor gene inactivated by promoter methylation in Colorectal Cancer
por: Guo, Xiaohong, et al.
Publicado: (2020)

MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10
por: Qi, Ying, et al.
Publicado: (2016)

Aberrant Methylation of PCDH8 is a Potential Prognostic Biomarker for Patients with Clear Cell Renal Cell Carcinoma
por: Lin, Ying-Li, et al.
Publicado: (2014)

PCDH10 Interacts With hTERT and Negatively Regulates Telomerase Activity
por: Zhou, Li-Na, et al.
Publicado: (2015)

Epigenomic and Functional Characterization of Junctophilin 3 (JPH3) as a Novel Tumor Suppressor Being Frequently Inactivated by Promoter CpG Methylation in Digestive Cancers
por: Hu, Xiaotong, et al.
Publicado: (2017)

The Clinical Significance and Biological Function of PCDH7 in Cervical Cancer
por: Zhang, Shitong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hevrocqv2q3inlclb6gcpb4fje